肽核酸，類肽和多肽定制合成服務(wù)以及肽核酸單體，類肽單體
普通會(huì)員
產(chǎn)品價(jià)格面議
產(chǎn)品品牌賽曼諾生物
最小起訂≥5 mg
供貨總量1000 mg
發(fā)貨期限自買家付款之日起 3 天內(nèi)發(fā)貨
瀏覽次數(shù)47
企業(yè)旺鋪http://cellmano.sjooo.com/
更新日期2015-02-06 13:44
會(huì)員級(jí)別：企業(yè)會(huì)員
已 繳 納：0.00 元保證金
我的勛章： [誠(chéng)信檔案]
在線客服：
企業(yè)二維碼： 企業(yè)名稱加二維碼
品牌： |
賽曼諾生物 |
所在地： |
安徽 合肥市 |
起訂： |
≥5 mg |
供貨總量： |
1000 mg |
有效期至： |
長(zhǎng)期有效 |
| Neuroendocrine Regulatory Peptide-1 (rat) NERP-1 (rat) |
C110H180N32O38 | 2558.83 | 954420-51-0 | H-Leu-Glu-Gly-Ser-Phe-Leu-Gly-Gly-Ser-Glu-Ala-Gly-Glu-Arg-Leu-Leu-Gln-Gln-Gly-Leu-Ala-Gln-Val-Glu-Ala-NH2 Trifluoroacetate salt |
| Neuroendocrine Regulatory Peptide-2 (human) NERP-2 (human) |
C173H288N56O57 | 4064.53 | Pyr-Ala-Glu-Ala-Thr-Arg-Gln-Ala-Ala-Ala-Gln-Glu-Glu-Arg-Leu-Ala-Asp-Leu-Ala-Ser-Asp-Leu-Leu-Leu-Gln-Tyr-Leu-Leu-Gln-Gly-Gly-Ala-Arg-Gln-Arg-Gly-Leu-Gly-NH2 Trifluoroacetate salt |
|
| Neuroendocrine Regulatory Peptide-2 (rat) NERP-2 (rat) |
C175H290N56O59 | 4122.57 | Pyr-Ala-Glu-Ala-Thr-Arg-Gln-Ala-Ala-Ala-Gln-Glu-Glu-Arg-Leu-Ala-Asp-Leu-Ala-Ser-Asp-Leu-Leu-Leu-Gln-Tyr-Leu-Leu-Gln-Gly-Gly-Ala-Arg-Gln-Arg-Asp-Leu-Gly-NH2 Trifluoroacetate salt |
|
| R 396 | C39H51N9O10 | 805.89 | 129809-09-2 | Ac-Leu-Asp-Gln-Trp-Phe-Gly-NH2 |
| GR 87389 | C47H65N9O9 | 900.08 | 141663-86-7 | Boc-Ala-Ala-D-Trp-Phe-D-Pro-Pro-Nle-NH2 |
| GR 94800 | C49H61N9O8 | 904.08 | 141636-65-9 | Bz-Ala-Ala-D-Trp-Phe-D-Pro-Pro-Nle-NH2 |
| L-659 877 | C38H50N8O7S | 762.93 | 125989-12-0 | Cyclo(-Gln-Trp-Phe-Gly-Leu-Met) |
| BIM-23127 | C62H71N11O9S2 | 1178.45 | 179188-73-9 | H-D-2-Nal-Cys-Tyr-D-Trp-Orn-Val-Cys-2-Nal-NH2 (Disulfide bond) |
| Neurokinin A, NKA, Substance K, Neurokinin α, Neuromedin L | C50H80N14O14S | 1133.34 | 86933-74-6 | H-His-Lys-Thr-Asp-Ser-Phe-Val-Gly-Leu-Met-NH2 Trifluoroacetate salt |
| (Tyr0)-Neurokinin A | C59H89N15O16S | 1296.51 | 116868-93-0 | H-Tyr-His-Lys-Thr-Asp-Ser-Phe-Val-Gly-Leu-Met-NH2 |
| Neurokinin A (4-10) | C34H54N8O10S | 766.92 | 97559-35-8 | H-Asp-Ser-Phe-Val-Gly-Leu-Met-NH2 |
| (β-Ala8)-Neurokinin A (4-10) | C35H56N8O10S | 780.94 | 127633-71-0 | H-Asp-Ser-Phe-Val-β-Ala-Leu-Met-NH2 |
| (Nle10)-Neurokinin A (4-10) | C35H56N8O10 | 748.88 | 110863-33-7 | H-Asp-Ser-Phe-Val-Gly-Leu-Nle-NH2 |
| (Trp7,β-Ala8)-Neurokinin A (4-10), R486 | C41H57N9O10S | 868.02 | 132041-95-3 | H-Asp-Ser-Phe-Trp-β-Ala-Leu-Met-NH2 |
| (Tyr5,D-Trp6·8·9,Arg-NH210)-Neurokinin A (4-10) | C57H68N14O10 | 1109.26 | 126050-12-2 | H-Asp-Tyr-D-Trp-Val-D-Trp-D-Trp-Arg-NH2 |
| (Tyr5,D-Trp6·8·9,Lys-NH210)-Neurokinin A (4-10) MEN 10376 |
C57H68N12O10 | 1081.24 | 135306-85-3 | H-Asp-Tyr-D-Trp-Val-D-Trp-D-Trp-Lys-NH2 |
| Neurokinin B, NKB | C55H79N13O14S2 | 1210.44 | 86933-75-7 | H-Asp-Met-His-Asp-Phe-Phe-Val-Gly-Leu-Met-NH2 |
| Biotinyl-Neurokinin B Biotinyl-Neurokinin β, Biotinyl-Neuromedin K, Biotinyl-NKB |
C65H93N15O16S3 | 1436.74 | 198328-30-2 | Biotinyl-Asp-Met-His-Asp-Phe-Phe-Val-Gly-Leu-Met-NH2 |
| (N-Me-Phe7)-Neurokinin B | C60H81N13O14S2 | 1272.51 | 110880-53-0 | H-Asp-Met-His-Asp-Phe-Phe-N-Me-Phe-Gly-Leu-Met-NH2 |
| (Pro7)-Neurokinin B | C55H77N13O14S2 | 1208.43 | 120814-48-4 | H-Asp-Met-His-Asp-Phe-Phe-Pro-Gly-Leu-Met-NH2 |
| (D-Pro2,D-Trp6·8,Nle10)-Neurokinin B | C67H87N15O14 | 1326.52 | 109212-72-8 | H-Asp-D-Pro-His-Asp-Phe-D-Trp-Val-D-Trp-Leu-Nle-NH2 |
| Neuromedin B | C52H73N15O12S | 1132.31 | 87096-84-2 | H-Gly-Asn-Leu-Trp-Ala-Thr-Gly-His-Phe-Met-NH2 |
| Neuromedin N | C38H63N7O8 | 745.96 | 92169-45-4 | H-Lys-Ile-Pro-Tyr-Ile-Leu-OH |
| Neuromedin S (human), NMS (human) | C173H265N53O44 | 3791.34 | H-Ile-Leu-Gln-Arg-Gly-Ser-Gly-Thr-Ala-Ala-Val-Asp-Phe-Thr-Lys-Lys-Asp-His-Thr-Ala-Thr-Trp-Gly-Arg-Pro-Phe-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH2 | |
| Biotinyl-Neuromedin S (human) Biotinyl-NMS (human) |
C183H279N55O46S | 4017.64 | Biotinyl-Ile-Leu-Gln-Arg-Gly-Ser-Gly-Thr-Ala-Ala-Val-Asp-Phe-Thr-Lys-Lys-Asp-His-Thr-Ala-Thr-Trp-Gly-Arg-Pro-Phe-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH2 | |
| Prepro-Neuromedin S (70-103) (human) Prepro-NMS (70-103) (human) |
C180H271N49O44S | 3857.50 | H-Phe-Leu-Phe-His-Tyr-Ser-Arg-Thr-Gln-Glu-Ala-Thr-His-Pro-Val-Lys-Thr-Gly-Phe-Pro-Pro-Val-His-Pro-Leu-Met-His-Leu-Ala-Ala-Lys-Leu-Ala-Asn-OH | |
| Neuromedin S (rat), NMS (rat) | C193H307N57O49S | 4241.98 | 843782-19-4 | H-Leu-Pro-Arg-Leu-Leu-His-Thr-Asp-Ser-Arg-Met-Ala-Thr-Ile-Asp-Phe-Pro-Lys-Lys-Asp-Pro-Thr-Thr-Ser-Leu-Gly-Arg-Pro-Phe-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH2 |
| Biotinyl-Neuromedin S (rat) Biotinyl-NMS (rat) |
C203H321N59O51S | 4436.22 | Biotinyl-Leu-Pro-Arg-Leu-Leu-His-Thr-Asp-Ser-Arg-Met-Ala-Thr-Ile-Asp-Phe-Pro-Lys-Lys-Asp-Pro-Thr-Thr-Ser-Leu-Gly-Arg-Pro-Phe-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH2 | |
| (Leu116)-Prepro-Neuromedin U (104-136) (human) Prepro-NMU (104-136) (human), (Leu116)-Prepro-NMU (104-136) (human) |
C177H276N46O45 | 3768.42 | H-Phe-Leu-Phe-His-Tyr-Ser-Lys-Thr-Gln-Lys-Leu-Gly-Leu-Ser-Asn-Val-Val-Ser-Ser-Val-Val-His-Pro-Leu-Leu-Gln-Leu-Val-Pro-His-Leu-His-Glu-OH | |
| Prepro-Neuromedin U (104-136) (human) Prepro-NMU (104-136) (human) |
C177H277N47O45 | 3783.44 | H-Phe-Leu-Phe-His-Tyr-Ser-Lys-Thr-Gln-Lys-Leu-Gly-Lys-Ser-Asn-Val-Val-Ser-Ser-Val-Val-His-Pro-Leu-Leu-Gln-Leu-Val-Pro-His-Leu-His-Glu-OH |
本網(wǎng)頁所展示的有關(guān)【L-659 877,BIM-23127_生化試劑_合肥賽曼諾生物科技有限公司】的信息/圖片/參數(shù)等由商一網(wǎng)的會(huì)員【合肥賽曼諾生物科技有限公司】提供，由商一網(wǎng)會(huì)員【合肥賽曼諾生物科技有限公司】自行對(duì)信息/圖片/參數(shù)等的真實(shí)性、準(zhǔn)確性和合法性負(fù)責(zé)，本平臺(tái)（本網(wǎng)站）僅提供展示服務(wù)，請(qǐng)謹(jǐn)慎交易，因交易而產(chǎn)生的法律關(guān)系及法律糾紛由您自行協(xié)商解決，本平臺(tái)（本網(wǎng)站）對(duì)此不承擔(dān)任何責(zé)任。您在本網(wǎng)頁可以瀏覽【L-659 877,BIM-23127_生化試劑_合肥賽曼諾生物科技有限公司】有關(guān)的信息/圖片/價(jià)格等及提供【L-659 877,BIM-23127_生化試劑_合肥賽曼諾生物科技有限公司】的商家公司簡(jiǎn)介、聯(lián)系方式等信息。
在您的合法權(quán)益受到侵害時(shí)，歡迎您向郵箱發(fā)送郵件，或者進(jìn)入《網(wǎng)站意見反饋》了解投訴處理流程，我們將竭誠(chéng)為您服務(wù)，感謝您對(duì)商一網(wǎng)的關(guān)注與支持！
